# Magnesium Sulfate in Addition to Bupivacaine in Ultrasound-guided Transmuscular Quadratus Lumborum Block for Post-Operative Analgesia After Total Hip Arthroplasty

> **NCT06956950** · PHASE2,PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 70 (estimated)

## Conditions studied

- Pain Score Reduction

## Interventions

- **DRUG:** Bupivacaine + Magnesium sulfate
- **DRUG:** Bupivacaine + saline

## Key facts

- **NCT ID:** NCT06956950
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2025-10-09
- **Final completion:** 2025-11
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06956950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06956950, "Magnesium Sulfate in Addition to Bupivacaine in Ultrasound-guided Transmuscular Quadratus Lumborum Block for Post-Operative Analgesia After Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06956950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*